[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.82.105. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
January 10, 2007

A Word From Our Moderator

Author Affiliations
 

Letters Section Editor: Robert M. Golub, MD, Senior Editor.

JAMA. 2007;297(2):156-157. doi:10.1001/jama.297.2.156-b

To the Editor: In their Commentary, Dr Kraemer and colleagues1 raise the important issue of exploring moderators of treatment outcome in randomized trials. I agree that reliance on the P value for hypothesis testing has limited value for clinicians who need to decide if a treatment is appropriate for a particular patient. There are also 2 other points to consider.

First Page Preview View Large
First page PDF preview
First page PDF preview
×